成人注意力缺陷多动障碍的治疗：临床视角
Treatment of adult ADHD: a clinical perspective.
作者信息
Geffen Josh, Forster Kieran
机构信息
Toowong Specialist Clinic, 2/54 Jephson St, Toowong, Brisbane, Queensland, 4066, Australia.
Better Minds Clinic, Brisbane, Queensland, Australia.
出版信息
Ther Adv Psychopharmacol. 2018 Jan;8(1):25-32. doi: 10.1177/2045125317734977. Epub 2017 Oct 25.
Abstract
Adult attention deficit/hyperactivity disorder (ADHD) has moved from the blurred edge of clinical focus to clear recognition as a prevalent and significant disorder in its own right. It is a relatively common comorbidity which if identified and treated may open the door to better outcomes for hard-to-treat patients. Conversely, failure to identify and treat adult ADHD is linked to negative outcomes. The recognition of the importance of adult ADHD in a subset of our patients challenges us to overcome our anxiety about this diagnosis and prevent the societal marginalization of vulnerable patients. Adult ADHD responds well to integrated pharmacological and psychotherapeutic intervention. Its treatment responsiveness reduces disability and allows the comorbidity which is typically present to be addressed. Mastering this challenge can make the diagnosis and treatment of adult ADHD a rewarding experience.
摘要
成人注意力缺陷多动障碍（ADHD）已从临床关注的模糊边缘，转变为被明确认定为一种自身普遍且重要的疾病。它是一种相对常见的共病情况，如果能够识别并加以治疗，可能为难以治疗的患者带来更好的治疗效果。相反，未能识别和治疗成人ADHD则与不良后果相关。认识到成人ADHD在部分患者中的重要性，促使我们克服对这一诊断的焦虑，并防止弱势患者被社会边缘化。成人ADHD对综合药物和心理治疗干预反应良好。其对治疗的反应性可减少残疾，并使通常存在的共病情况得以解决。应对这一挑战能够让成人ADHD的诊断和治疗成为一次有意义的经历。
相似文献
1
Treatment of adult ADHD: a clinical perspective.成人注意力缺陷多动障碍的治疗：临床视角
Ther Adv Psychopharmacol. 2018 Jan;8(1):25-32. doi: 10.1177/2045125317734977. Epub 2017 Oct 25.
2
A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.对多动症合并物质使用障碍患者使用精神刺激药物所产生问题的定性综述。
Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908x280707. Epub 2008 Apr 1.
3
Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative review.儿童注意缺陷多动障碍伴发焦虑障碍的管理：叙述性综述。
Int Clin Psychopharmacol. 2021 Jan;36(1):1-11. doi: 10.1097/YIC.0000000000000338.
4
Cognitive-behavioural therapy in medication-treated adults with attention-deficit/hyperactivity disorder and co-morbid psychopathology: a randomized controlled trial using multi-level analysis.药物治疗的注意缺陷多动障碍合并共病精神病理学成年患者的认知行为疗法：一项采用多层次分析的随机对照试验
Psychol Med. 2015 Oct;45(13):2793-804. doi: 10.1017/S0033291715000756. Epub 2015 May 29.
5
Insomnia Disorder in Adult Attention-Deficit/Hyperactivity Disorder Patients: Clinical, Comorbidity, and Treatment Correlates.成人注意力缺陷多动障碍患者的失眠症：临床特征、共病情况及治疗相关性
Front Psychiatry. 2021 May 26;12:663889. doi: 10.3389/fpsyt.2021.663889. eCollection 2021.
6
Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.儿童及成人注意力缺陷多动障碍药物治疗的疗效及安全性局限
CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004.
7
Bright light therapy versus physical exercise to prevent co-morbid depression and obesity in adolescents and young adults with attention-deficit / hyperactivity disorder: study protocol for a randomized controlled trial.明亮光疗法与体育锻炼预防注意力缺陷/多动障碍青少年和青年共病抑郁和肥胖：一项随机对照试验的研究方案
Trials. 2018 Feb 26;19(1):140. doi: 10.1186/s13063-017-2426-1.
8
[Awareness of adult attention-deficit/hyperactivity disorder (ADHD) in Greece].[希腊对成人注意力缺陷/多动障碍（ADHD）的认知]
Psychiatriki. 2012 Jun;23 Suppl 1:60-5.
9
Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?注意缺陷多动障碍合并长QT综合征患儿的兴奋剂治疗：一种安全的联合治疗方法？
Heart Rhythm. 2015 Aug;12(8):1807-12. doi: 10.1016/j.hrthm.2015.04.043. Epub 2015 May 5.
10
Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.成人注意力缺陷多动障碍（ADHD）药物治疗的有效性——卫生技术评估
GMS Health Technol Assess. 2010 Sep 7;6:Doc13. doi: 10.3205/hta000091.
引用本文的文献
1
Real-world effectiveness of a widely available digital health program in adults reporting a lifetime diagnosis of ADHD.一项广泛应用的数字健康项目在报告有终身多动症诊断的成年人中的真实世界有效性。
Npj Ment Health Res. 2025 Aug 22;4(1):38. doi: 10.1038/s44184-025-00157-3.
2
Assessment of Potential Factors Influencing Attention-Deficit/Hyperactivity Disorder Drug Adherence: A Database Study.影响注意力缺陷多动障碍药物依从性的潜在因素评估：一项数据库研究。
Int J Environ Res Public Health. 2025 May 1;22(5):716. doi: 10.3390/ijerph22050716.
3
Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records.通过跨物种分析、药物靶点孟德尔随机化以及病历临床证据验证L型钙通道阻滞剂氨氯地平作为一种新型多动症治疗药物的有效性。
Neuropsychopharmacology. 2025 Jun;50(7):1145-1155. doi: 10.1038/s41386-025-02062-x. Epub 2025 Feb 14.
4
Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study is the United States.真实世界分析：仅患有注意缺陷多动障碍（ADHD）和伴有合并精神共病的成年人的治疗改变和反应：来自美国电子健康记录数据库的研究结果。
BMC Psychiatry. 2024 Sep 16;24(1):618. doi: 10.1186/s12888-024-05994-8.
5
Assessment of centanafadine in adults with attention-deficit/hyperactivity disorder: A matching-adjusted indirect comparison vs lisdexamfetamine dimesylate, atomoxetine hydrochloride, and viloxazine extended-release.评估 centanafadine 治疗成人注意缺陷多动障碍：与 lisdexamfetamine dimesylate、盐酸托莫西汀和维洛沙嗪缓释剂的匹配调整间接比较。
J Manag Care Spec Pharm. 2024 Jun;30(6):528-540. doi: 10.18553/jmcp.2024.30.6.528.
6
A Retrospective Chart Review Evaluating the Changes in Depressive Symptoms in Adult Patients With Attention-Deficit/Hyperactivity Disorder (ADHD) With the Treatment of the Underlying ADHD.一项回顾性病历审查，评估患有注意力缺陷/多动障碍（ADHD）的成年患者在治疗潜在ADHD后抑郁症状的变化。
Cureus. 2024 Apr 2;16(4):e57473. doi: 10.7759/cureus.57473. eCollection 2024 Apr.
7
Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes.注意缺陷多动障碍药物与工作残疾及心理健康结局。
JAMA Netw Open. 2024 Mar 4;7(3):e242859. doi: 10.1001/jamanetworkopen.2024.2859.
8
A review of recent treatments for adults living with attention-deficit/hyperactivity disorder.成人注意力缺陷/多动障碍近期治疗方法综述
S Afr J Psychiatr. 2023 Dec 5;29:2152. doi: 10.4102/sajpsychiatry.v29i0.2152. eCollection 2023.
9
The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden.社会人口统计学和临床因素在瑞典年轻人注意力缺陷多动障碍药物治疗起始与停药过程中的作用。
Front Psychiatry. 2023 Apr 24;14:1152286. doi: 10.3389/fpsyt.2023.1152286. eCollection 2023.
10
Novel non-stimulants rescue hyperactive phenotype in an adgrl3.1 mutant zebrafish model of ADHD.新型非兴奋剂可挽救 ADHD 模型斑马鱼中 adgrl3.1 突变体的多动表型。
Neuropsychopharmacology. 2023 Jul;48(8):1155-1163. doi: 10.1038/s41386-022-01505-z. Epub 2022 Nov 18.
本文引用的文献
1
Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes.注意力缺陷/多动障碍用药与机动车碰撞风险之间的关联
JAMA Psychiatry. 2017 Jun 1;74(6):597-603. doi: 10.1001/jamapsychiatry.2017.0659.
2
Efficacy of Cognitive Behavioral Therapy With and Without Medication for Adults With ADHD: A Randomized Clinical Trial.认知行为疗法联合与不联合药物治疗成人注意缺陷多动障碍的疗效：一项随机临床试验。
J Atten Disord. 2020 Apr;24(6):889-903. doi: 10.1177/1087054716671197. Epub 2016 Oct 6.
3
Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?成瘾患者注意力缺陷多动障碍的药物治疗：文献告诉了我们什么？
Harv Rev Psychiatry. 2017 Mar/Apr;25(2):50-64. doi: 10.1097/HRP.0000000000000122.
4
Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis.儿童和成人注意力缺陷多动障碍患者的皮质下脑容量差异：一项横断面大型分析。
Lancet Psychiatry. 2017 Apr;4(4):310-319. doi: 10.1016/S2215-0366(17)30049-4. Epub 2017 Feb 16.
5
Brain imaging genetics in ADHD and beyond - Mapping pathways from gene to disorder at different levels of complexity.注意缺陷多动障碍及其他相关疾病的脑影像遗传学：在不同复杂程度的水平上从基因到疾病的映射途径。
Neurosci Biobehav Rev. 2017 Sep;80:115-155. doi: 10.1016/j.neubiorev.2017.01.013. Epub 2017 Jan 31.
6
Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review.成人注意缺陷多动障碍的药物和非药物治疗：荟萃综述。
Evid Based Ment Health. 2017 Feb;20(1):4-11. doi: 10.1136/eb-2016-102415. Epub 2016 Dec 19.
7
Positive effects of transcranial direct current stimulation in adult patients with attention-deficit/hyperactivity disorder - A pilot randomized controlled study.经颅直流电刺激对成人注意缺陷多动障碍患者的积极影响——一项初步随机对照研究。
Psychiatry Res. 2017 Jan;247:28-32. doi: 10.1016/j.psychres.2016.11.009. Epub 2016 Nov 10.
8
A randomized controlled trial reporting functional outcomes of cognitive-behavioural therapy in medication-treated adults with ADHD and comorbid psychopathology.一项随机对照试验，报告了认知行为疗法对接受药物治疗的患有注意力缺陷多动障碍及共病精神病理学的成年人的功能结局。
Eur Arch Psychiatry Clin Neurosci. 2017 Apr;267(3):267-276. doi: 10.1007/s00406-016-0735-0. Epub 2016 Oct 17.
9
The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder.双相情感障碍患者使用哌甲酯后出现治疗中躁狂发作的风险
Am J Psychiatry. 2017 Apr 1;174(4):341-348. doi: 10.1176/appi.ajp.2016.16040467. Epub 2016 Oct 3.
10
Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review.成人注意缺陷多动障碍与共患躯体疾病：系统文献综述。
J Atten Disord. 2018 Feb;22(3):203-228. doi: 10.1177/1087054716669589. Epub 2016 Sep 1.
Zotero 插件